Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 3 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
21 59.8 months Indolent NHL 5 Biologic therapy
Radiation
Centre Hospitalier de l'Université de Montréal Canada 4/2014
Treatment Details: Patients: This study involved 93 indolent non-Hodgkin lymphoma patients who had received prior rituximab-based biologic therapy. The median patient age was 59 years and 53.8% were male.
 
22 59.0 months Recurrent GBM Chemotherapy
Radiation
University of Heidelberg Germany 5/2008
Treatment Details: Patients: This study involved 25 patients with recurrent or progressive gliomas. Glioblastoma was the most common form, in 32% of the patients. Other patients had oligoastrocytoma, oligod
 
23 58.9 months Non-castrate metastatic prostate cancer 5 Chemotherapy
Hormone
Institut Paoli-Calmettes France 2/2013
Treatment Details: Patients: This phase 3 study involved non-castrate (hormone-sensitive) prostate cancer patients who were divided into two separate treatment groups. Group A consisted of 192 men with a med
 
24 57.3 months Ovarian cancer 5 Chemotherapy
M.D. Anderson Cancer Center Orlando United States 12/2011
Treatment Details: Patients: This phase III study involved women with ovarian cancer who were divided into two separate treatment groups. Group A consisted of 417 patients with a median age of 60 years. Gro
 
25 57.0 months Stage III Ovarian cancer 4 Chemotherapy
University of Arizona Cancer Center United States 3/2004
Treatment Details: Patients: This phase II study involved 97 women with stage III epithelial ovarian cancer. Treatment: The treatment consisted of a chemotherapy drug called altretamine. Toxicity: Grade
 
26 56.6 months Advanced ovarian cancer 4 Chemotherapy
Surgery
Hyogo College of Medicine Japan 3/2013
Treatment Details: Patients: This phase 2 study involved 37 advanced ovarian cancer patients with a median age of 55 years. Treatment: Patients were treated with interval debulking surgery and chemotherap
 
27 56.3 months Stage II and IIIA NSCLC 5 Chemotherapy
Radiation
Surgery
Washington University Medical Center United States 5/2005
Treatment Details: Patients: This Phase II study involved 88 patients diagnosed with non-small-cell lung cancer (resected stage II or IIIA) Fifty-seven patients were men, and thirty-one were women. Forty-nin
 
28 55.2 months Muscle-Invasive Bladder Cancer 5 Chemotherapy
San Camillo and Forlanini Hospitals Italy 1/2015
Treatment Details: Patients: This phase 3 study involved patients with muscle-invasive urothelial carcinoma of the bladder who had previous radical cystectomy surgery. Patients were divided into two separate
 
29 54.2 months Non-castrate metastatic prostate cancer 4 Hormone
Institut Paoli-Calmettes France 2/2013
Treatment Details: Patients: This phase 3 study involved non-castrate (hormone-sensitive) prostate cancer patients who were divided into two separate treatment groups. Group A consisted of 192 men with a med
 
30 53.7 months Advanced prostate cancer 4 Chemotherapy
Hormone
University of Texas Health Science Center at Houston United States 6/2013
Treatment Details: Patients: This phase 2 study involved 45 advanced prostate cancer patients with a median patient age of 65 years. Treatment: Patients were treated with androgen deprivation therapy and
 
Page 3 of 187  | Previous Page  | Next Page